Nutrition
Volume 21, Issue 9 , Pages 977-985 , September 2005

Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future

Received 12 November 2004 ,Accepted 1 February 2005.

References 

  1. López-Soriano J , Carbó N , Tessitore L , López-Soriano FJ , Argilés JM . Leptin and tumour growth in the rat . Int J Cancer . 1999;81:726–729
  2. Sato T , Meguid MM , Miyata G , Chen C , Hatakeyama K . Does leptin really influence cancer anorexia? . Nutrition . 2002;18:82–83
  3. Kowalczuk A , Wiecek A , Franek E , Kokot F . Plasma concentration of leptin, neuropeptide Y and tumour necrosis factor alpha in patients with cancers, before and after radio- and chemotherapy . Pol Arch Med Wewn . 2001;106:657–668
  4. Tessitore L , Vizio B , Jenkins O , De Stefano I , Ritossa C , Argilés JM , et al.   Leptin expression in colorectal and breast cancer patients . Int J Mol Med . 2000;5:421–426
  5. Brown DR , Berkowitz DE , Breslow MJ . Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer . J Clin Endocrinol Metab . 2001;86:162–166
  6. Aleman MR , Santolaria F , Batista N , de La Vega M , Gonzalez-Reimers E , Milena A , et al.   Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? . Cytokine . 2002;19:21–26
  7. Mantovani G , Maccio A , Mura L , Massa E , Mudu MC , Mulas C , et al.   Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites . J Mol Med . 2000;78:554–561
  8. Mantovani G , Maccio A , Madeddu C , Mura L , Massa E , Mudu MC , et al.   Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites . J Mol Med . 2000;179:406–414
  9. Korbonits M , Grossman AB . Ghrelin (update on a novel hormonal system) . Eur J Endocrinol . 2004;151:S67–S70
  10. Hanada T , Toshinai K , Date Y , Kajimura N , Tsukada T , Hayashi Y , et al.   Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells . Metabolism . 2004;53:84–88
  11. Wisse BE , Schwartz MW , Cummings DE . Melanocortin signaling and anorexia in chronic disease states . Ann NY Acad Sci . 2003;994:275–281
  12. Marks DL , Cone RD . The role of the melanocortin-3 receptor in cachexia . Ann NY Acad Sci . 2003;994:258–266
  13. Plata-Salaman CR . Central nervous system mechanisms contributing to the cachexia-anorexia syndrome . Nutrition . 2000;16:1009–1012
  14. Chance WT , Balasubramaniam A , Dayal R , Brown J , Fischer JE . Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumour-bearing rats . Life Sci . 1994;54:1869–1874
  15. King PJ , Widdowson PS , Doods H , Williams G . Effect of cytokines on hypothalamic neuropeptide Y release in vitro . Peptides . 2000;21:143–146
  16. Laviano A , Russo M , Freda F , Rossi-Fanelli F . Neurochemical mechanisms for cancer anorexia . Nutrition . 2002;18:100–105
  17. Bing C , Taylor S , Tisdale MJ , Williams G . Cachexia in MAC16 adenocarcinoma (suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y) . J Neurochem . 2001;79:1004–1012
  18. Strassmann G , Fong M , Freter CE , Windsor S , D’Alessandro F , Nordan RP . Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo . J Clin Invest . 1993;92:2152–2159
  19. Enomoto A , Rho MC , Fukami A , Hiraku O , Komiyama K , Hayashi M . Suppression of cancer cachexia by 20S,21-epoxy-resibufogenin-3-acetate—a novel nonpeptide IL-6 receptor antagonist . Biochem Biophys Res Commun . 2004;323:1096–1102
  20. Barton BE , Cullison J , Jackson J , Murphy T . A model that reproduces syndromes associated with human multiple myeloma in nonirradiated SCID mice . Proc Soc Exp Biol Med . 2000;223:190–197
  21. Barton BE , Murphy TF . Cancer cachexia is mediated in part by the induction of IL-6–like cytokines from the spleen . Cytokine . 2001;16:251–257
  22. Negri DR , Mezzanzanica D , Sacco S , Gadina M , Benigni F , Cajola L , et al.   Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours . Cytokine . 2001;15:27–38
  23. Zaki MH , Nemeth JA , Trikha M . CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice . Int J Cancer . 2004;111:592–595
  24. Matthys P , Heremans H , Opdenakker G , Billiau A . Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia . Eur J Cancer . 1991;27:182–187
  25. Henderson JT , Mullen BJ , Roder JC . Physiological effects of CNTF-induced wasting . Cytokine . 1996;8:784–793
  26. Wang MC , Forsberg NE . Effects of ciliary neurotrophic factor (CNTF) on protein turnover in cultured muscle cells . Cytokine . 2000;12:41–48
  27. Adams SH . Uncoupling protein homologs (emerging views of physiological function) . J Nutr . 2000;130:711–714
  28. Busquets S , Sanchis D , Alvarez B , Ricquier D , López-Soriano FJ , Argilés JM . In the rat, TNF-α administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle (a possible mechanism for cytokine-induced thermogenesis?) . FEBS Lett . 1998;440:348–350
  29. Busquets S , Aranda X , Ribas-Carbó M , Azcon-Bieto J , López-Soriano FJ , Argilés JM . Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria . Cytokine . 2003;22:1–4
  30. Argilés JM , López-Soriano FJ . Catabolic proinflammatory cytokines . Curr Opin Clin Nutr Metab Care . 1998;1:245–251
  31. Bossola M , Muscaritoli M , Costelli P , Bellantone R , Pacelli F , Busquets S , et al.   Increased muscle ubiquitin mRNA levels in gastric cancer patients . Am J Physiol . 2001;280:R1518–R1523
  32. Baracos VE . Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia . Nutrition . 2000;16:1015–1018
  33. Alvarez B , Quinn LS , Busquets S , Quiles MT , López-Soriano FJ , Argilés JM . Tumour necrosis factor-alpha exerts interleukin-6–dependent and -independent effects on cultured skeletal muscle cells . Biochim Biophys Acta . 2002;1542:66–72
  34. Sharma R , Anker SD . Cytokines, apoptosis and cachexia (the potential for TNF-α antagonism) . Int J Cardiol . 2002;85:161–171
  35. van Royen M, Carbó N, Busquets S, Alvarez B, Quinn LS, López-Soriano FJ, et al. DNA fragmentation occurs in skeletal muscle during tumour growth (a link with cancer cachexia?) . Biochem Biophys Res Commun . 2000;270:533–537
  36. Belizario JE , Lorite MJ , Tisdale MJ . Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia . Br J Cancer . 2001;84:1135–1140
  37. Carbó N , Busquets S , van Royen M , Alvarez B , López-Soriano FJ , Argilés JM . TNF-α is involved in activating DNA fragmentation in murine skeletal muscle . Br J Cancer . 2002;86:1012–1016
  38. Dunlop RJ , Campbell CW . Cytokines and advanced cancer . J Pain Symptom Manage . 2000;20:214–232
  39. Cahlin C , Korner A , Axelsson H , Wang W , Lundholm K , Svanberg E . Experimental cancer cachexia (the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia) . Cancer Res . 2000;60:5488–5493
  40. Costa G , Holland JF . Effects of Krebs-2 carcinoma on the lipid metabolism of male Swiss mice . Cancer Res . 1966;22:1081–1083
  41. Kitada S , Hays EF , Mead JF . Characterization of a lipid mobilizing factor from tumors . Prog Lipid Res . 1981;20:823–826
  42. Masuno H , Yamasaki N , Okuda H . Purification and characterization of a lipolytic factor (toxohormone L) from cell free fluid of ascites sarcoma 180 . Cancer Res . 1981;41:284–288
  43. Khan S , Tisdale MJ . Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor . Int J Cancer . 1999;80:444–447
  44. Hirai K , Hussey HJ , Barber MD , Price SA , Tisdale MJ . Biological evaluation of a lipid-mobilising factor isolated from the urine of cancer patients . Cancer Res . 1998;58:2359–2365
  45. Hirai K , Ishiko O , Tisdale M . Mechanism of depletion of liver glycogen in cancer cachexia . Biochim Biophys Res Commun . 1997;241:49–52
  46. Ishiko O, Yasui T, Hirai K, Honda K, Sumi T, Nishimura S, et al. Lipolytic activity of anemia-inducing substance from tumor-bearing rabbits . Nutr Cancer . 1999;33:201–205
  47. Todorov P , Cariuk P , McDevitt T , Coles B , Fearon K , Tisdale M . Characterization of a cancer cachectic factor . Nature . 1996;22:739–742
  48. Lorite MJ , Cariuk P , Tisdale MJ . Induction of muscle protein degradation by a tumour factor . Br J Cancer . 1997;76:1035–1040
  49. Wigmore SJ , Todorov PT , Barber MD , Ross JA , Tisdale MJ , Fearon KC . Characteristics of patients with pancreatic cancer expressing a novel cancer cachexia factor . Br J Surg . 2000;87:53–58
  50. Lorite MJ , Thompson MG , Drake JL , Carling G , Tisdale MJ . Mechanism of muscle protein degradation induced by a cancer cachectic factor . Br J Cancer . 1998;78:850–856
  51. Smith HJ , Lorite MJ , Tisdale MJ . Effects of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts (modulation by eicosapentaenoic acid) . Cancer Res . 1999;59:5507–5513
  52. Smith HJ , Wyke SM , Tisdale MJ . Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes . Br J Cancer . 2004;90:1850–1857
  53. Penner CG , Gang G , Wray C , Fischer JE , Hasselgren PO . The transcription factors NF-kappaB and AP-1 are differentially regulated in skeletal muscle during sepsis . Biochem Biophys Res Commun . 2001;281:1331–1336
  54. Costelli P , Muscaritoli M , Bossola M , Moore-Carrasco R , Crepaldi S , Grieco G , et al.   Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation . Int J Oncol . 2005;26:1663–1668
  55. Busquets S , Carbó N , Almendro V , Quiles MT , López-Soriano FJ , Argilés JM . Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model . Cancer Lett . 2001;167:33–38
  56. Moore-Carrasco R , Busquets S , Almendro V , Palanki M , López-Soriano FJ , Argilés JM . The AP-1/nF-kB double inhibitor (SP100030) can revert muscle wasting during experimental cancer cachexia . Int J Oncol . 2005; in press.
  57. Fernandez-Celemin L , Pasko N , Blomart V , Thissen JP . Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha . Am J Physiol . 2002;283:E1279–E1290
  58. Li YP , Schwartz RJ , Waddell ID , Holloway BR , Reid MB . Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha . FASEB J . 1998;12:871–880
  59. Li YP , Reid MB . NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes . Am J Physiol Regul Integr Comp Physiol . 2000;279:R1165–R1170
  60. Brenner DA , O’Hara M , Angel P , Chojkier M , Karin M . Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha . Nature . 1989;337:661–663
  61. Thinakaran G , Ojala J , Bag J . Expression of c-jun/AP-1 during myogenic differentiation in mouse C2C12 myoblasts . FEBS Lett . 1993;319:271–276
  62. Cai D , Frantz JD , Tawa NE , Melendez PA , Oh BC , Lidov HG , et al.   IKKbeta/NF-kappaB activation causes severe muscle wasting in mice . Cell . 2004;119:285–298
  63. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products . J Clin Invest . 2004;114:370–378
  64. Diffee GM , Kalfas K , Al-Majid S , McCarthy DO . Altered expression of skeletal muscle myosin isoforms in cancer cachexia . Am J Physiol Cell Physiol . 2002;283:C1376–C1382
  65. Penner G , Gang G , Sun X , Wray C , Hasselgren PO . C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle . Am J Physiol . 2002;282:R439–R444
  66. Guttridge DC , Mayo MW , Madrid LV , Wang CY , Baldwin AS . NF-kappaB-induced loss of MyoD messenger RNA (possible role in muscle decay and cachexia) . Science . 2000;289:2363–2366
  67. Coletti D , Yang E , Marazzi G , Sassoon D . TNF-α inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways . EMBO J . 2002;21:631–642
  68. Puigserver P , Rhee J , Lin J , Wu Z , Yoon JC , Zhang CY , et al.   Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1 . Mol Cell . 2001;8:971–982
  69. Balazs C , Kiss E . Immunological aspects of the effect of pentoxifylline . Acta Microbiol Immunol Hung . 1994;41:121–126
  70. Goldberg RM , Loprinzi CL , Mailliard JA , O’Fallon JR , Krook JE , Ghosh C , et al.   Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial . J Clin Oncol . 1995;13:2856–2859
  71. Peuckmann V , Fisch M , Bruera E . Potential novel uses of thalidomide (focus on palliative care) . Drugs . 2000;60:273–292
  72. Khan ZH , Simpson EJ , Cole AT , Holt M , MacDonald I , Pye D , et al.   Oesophageal cancer and cachexia (the effect of short-term treatment with thalidomide on weight loss and lean body mass) . Aliment Pharmacol Ther . 2003;17:677–682
  73. Babcock TA , Helton WS , Hong D , Espat NJ . Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-alpha production . Surg Infect . 2002;3:145–149 (Larchmt)
  74. Liu Y , Gong L , Li D , Feng Z , Zhao L , Dong T . Effects of fish oil on lymphocyte proliferation, cytokine production and intracellular signalling in weanling pigs . Arch Tierernahr . 2003;57:151–165
  75. Trebble T , Arden NK , Stroud MA , Wootton SA , Burdge GC , Miles EA , et al.   Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation . Br J Nutr . 2003;90:405–412
  76. Costelli P, Carbó N, Tessitore L, Bagby GJ, López-Soriano FJ, Argilés JM, et al. Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model . J Clin Invest . 1993;92:2783–2789
  77. Reinhart K , Wiegand-Lohnert C , Grimminger F , Kaul M , Withington S , Treacher D , et al.   Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody fragment, MAK 195F, in patients with sepsis and septic shock (a multicenter, randomized, placebo-controlled, dose-ranging study) . Crit Care Med . 1996;24:733–742
  78. Kurtovic J , Segal I . Recent advances in biological therapy for inflammatory bowel disease . Trop Gastroenterol . 2004;25:9–14
  79. Rutgeerts P , Van Assche G , Vermeire S . Optimizing anti-TNF treatment in inflammatory bowel disease . Gastroenterology . 2004;126:1593–1610
  80. Mori K , Fujimoto-Ouchi K , Ishikawa T , Sekiguchi F , Ishitsuka H , Tanaka Y . Murine interleukin-12 prevents the development of cancer cachexia in a murine model . Int J Cancer . 1996;67:849–855
  81. Quinn LS , Haugk KL , Grabstein KH . Interleukin-15 (a novel anabolic cytokine for skeletal muscle) . Endocrinology . 1995;136:3669–3672
  82. Carbó N , López-Soriano J , Costelli P , Busquets S , Alvarez B , Baccino FM , et al.   Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats . Br J Cancer . 2000;83:526–531
  83. Okamoto T . NSAID zaltoprofen improves the decrease in body weight in rodent sickness behavior models (proposed new applications of NSAID) . Int J Mol Med . 2002;9:369–372
  84. Niu Q , Li T , Liu A . Cytokines in experimental cancer cachexia . Zhonghua Zhong Liu Za Zhi . 2001;23:382–384
  85. Lundholm K , Daneryd P , Bosaeus I , Korner U , Lindholm E . Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease (effects on survival, metabolism, and function) . Cancer . 2004;100:1967–1977
  86. Kawamura I , Morishita R , Tomita N , Lacey E , Aketa M , Tsujimoto S , et al.   Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model . Gene Ther . 1999;6:91–97
  87. Kawamura I , Morishita R , Tsujimoto S , Manda T , Tomoi M , Tomita N , et al.   Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice . Gene Ther . 2001;8:905–912

PII: S0899-9007(05)00159-0

doi: 10.1016/j.nut.2005.02.003

Nutrition
Volume 21, Issue 9 , Pages 977-985 , September 2005

Article Tools

* Image Usage & Resolution